المؤلفون: Rye, IH, Lundin, P, Maner, S, Fjelldal, R, Naume, B, Wigler, M, Hicks, J, Borresen-Dale, AL, Zetterberg, A, Russnes, HG

المصدر: Genes, chromosomes & cancer. 54(4):235-248

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:130768182

المؤلفون: Van Loo, P, Nordgard, SH, Lingjaerde, OC, Russnes, HG, Rye, IH, Sun, W, Weigman, VJ, Marynen, P, Zetterberg, A, Naume, B, Perou, CM, Borresen-Dale, AL, Kristensen, VN

المصدر: Proceedings of the National Academy of Sciences of the United States of America. 107(39):16910-16915

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:121352524

المؤلفون: Russnes, HG, Vollan, HKM, Lingjaerde, OC, Krasnitz, A, Lundin, P, Naume, B, Sorlie, T, Borgen, E, Rye, IH, Langerod, A, Chin, SF, Teschendorff, AE, Stephens, PJ, Maner, S, Schlichting, E, Baumbusch, LO, Karesen, R, Stratton, MP, Wigler, M, Caldas, C, Zetterberg, A, Hicks, J, Borresen-Dale, AL

المصدر: Science translational medicine. 2(38)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:122168488

المؤلفون: Glodzik, D, Morganella, S, Davies, H, Simpson, PT, Li, Y, Zou, X, Diez-Perez, J, Staaf, J, Alexandrov, LB, Smid, M, Brinkman, AB, Rye, IH, Russnes, H, Raine, K, Purdie, CA, Lakhani, Thompson, AM, Birney, E, Stunnenberg, HG, Van De Vijver, MJ, Martens, JWM, Børresen-Dale, A-L, Richardson, AL, Kong, G, Viari, A, Easton, D, Evan, G, Campbell, PJ, Stratton, MR, Nik-Zainal, S

مصطلحات موضوعية: breast cancer, genetics research, genomics, 3. Good health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c4731ff889d86b21a8f6e1d7ef053f85

المؤلفون: Otterlei Fjørtoft M; Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radium Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Huse K; Department of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radium Hospital, Oslo, Norway., Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radium Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ingrye@rr-research.no.

المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 May 23; Vol. 63, pp. 359-367. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Breast Neoplasms*/immunology , Breast Neoplasms*/pathology , Disease Progression*, Humans ; Female ; Prognosis ; Lymphocytes, Tumor-Infiltrating/immunology ; Killer Cells, Natural/immunology

المؤلفون: Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Huse K; Department of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital Radiumhospitalet, Norway.; KG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Norway., Josefsson SE; Department of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital Radiumhospitalet, Norway.; KG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Norway., Kildal W; Division of Cancer Medicine, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Danielsen HE; Division of Cancer Medicine, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.; Department of Informatics, University of Oslo, Norway.; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, UK., Schlichting E; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway., Garred Ø; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Norway., Riis ML; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Norway., Osbreac; Oslo Breast Cancer Consortium, Oslo University Hospital, Norway., Lingjaerde OC; Institute for Bioinformatics, University of Oslo, Norway., Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital Radiumhospitalet, Norway.; KG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Norway., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Norway.

المصدر: Molecular oncology [Mol Oncol] 2022 Jan; Vol. 16 (1), pp. 88-103. Date of Electronic Publication: 2021 Jul 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology, CD8-Positive T-Lymphocytes ; Female ; Humans ; Immunosuppression Therapy ; Lymph Nodes/pathology ; Melanoma ; Skin Neoplasms ; T-Lymphocyte Subsets/pathology ; Melanoma, Cutaneous Malignant

المؤلفون: Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida, USA., Stein S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Metzger Filho O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Eng J; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Kingston NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rye IH; Department of Pathology, Division of Laboratory Medicine, and Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Trinh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Murphy KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Marangoni E; Department of Translational Research, Institut Curie, Paris, France., Cristea S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA., Oakes B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Russnes HG; Department of Pathology, Division of Laboratory Medicine, and Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Spellman PT; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.; Department of Molecular and Medical Genetics, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA., Bucher E; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Hu Z; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Chin K; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Gray JW; OHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Michor F; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA.

المصدر: JCI insight [JCI Insight] 2021 Jun 08; Vol. 6 (11). Date of Electronic Publication: 2021 Jun 08.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Breast Neoplasms/*drug therapy , Class I Phosphatidylinositol 3-Kinases/*genetics , Drug Resistance, Neoplasm/*genetics , Epithelial Cells/*metabolism , Macrophages/*metabolism , Receptor, ErbB-2/*genetics, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/therapeutic use ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Class I Phosphatidylinositol 3-Kinases/metabolism ; DNA Copy Number Variations ; Female ; Fibroblasts/metabolism ; Humans ; Middle Aged ; Mutation ; Neoplasm Transplantation ; Receptor, ErbB-2/antagonists & inhibitors ; Receptor, ErbB-2/metabolism ; Trastuzumab/therapeutic use ; Tumor Microenvironment ; Vesicular Transport Proteins/metabolism

المؤلفون: Taylor-King JP; Mathematical Institute, University of Oxford, Oxford, UK.; Department of Integrated Mathematical Oncology, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Institute of Molecular Systems Biology, Department of Biology, ETHZ, Zurich, Switzerland., Baratchart E; Department of Integrated Mathematical Oncology, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Dhawan A; Department of Oncology, University of Oxford, Oxford, UK., Coker EA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK., Rye IH; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway., Russnes H; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Chapman SJ; Mathematical Institute, University of Oxford, Oxford, UK., Basanta D; Department of Integrated Mathematical Oncology, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Marusyk A; Department of Cancer Imaging and Metabolism, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

المصدر: Mathematical medicine and biology : a journal of the IMA [Math Med Biol] 2019 Mar 14; Vol. 36 (1), pp. 93-112.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Published for the Institute of Mathematics and its Applications by Oxford University Press Country of Publication: England NLM ID: 101182345 Publication Model: Print Cited Medium: Internet ISSN: 1477-8602 (Electronic) Linking ISSN: 14778599 NLM ISO Abbreviation: Math Med Biol Subsets: MEDLINE

مواضيع طبية MeSH: Models, Biological*, Paracrine Communication/*physiology , Tumor Microenvironment/*physiology, Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Breast Neoplasms/physiopathology ; Cell Line, Tumor ; Computer Simulation ; Female ; Gene Amplification ; Histological Techniques ; Humans ; In Situ Hybridization, Fluorescence ; Mathematical Concepts ; Mutation ; Paracrine Communication/genetics ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Signal Transduction/physiology ; Tumor Microenvironment/genetics

المؤلفون: Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway., Trinh A; Cancer Research UK, Cambridge Institute, University of Cambridge, UK., Saetersdal AB; Department of Oncology, Oslo University Hospital, Norway., Nebdal D; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway., Lingjaerde OC; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway.; Biomedical Informatics Division, Department of Computer Science, University of Oslo, Norway., Almendro V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway.; Department of Clinical Medicine, University of Oslo, Norway., Helland Å; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway.; Department of Oncology, Oslo University Hospital, Norway.; Department of Clinical Medicine, University of Oslo, Norway., Markowetz F; Cancer Research UK, Cambridge Institute, University of Cambridge, UK., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Norway.; Department of Pathology, Oslo University Hospital, Norway.

المصدر: Molecular oncology [Mol Oncol] 2018 Nov; Vol. 12 (11), pp. 1838-1855. Date of Electronic Publication: 2018 Sep 21.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism , Breast Neoplasms*/mortality , Breast Neoplasms*/therapy , Drug Resistance, Neoplasm* , Gene Dosage* , Neoadjuvant Therapy* , Receptor, ErbB-2*/biosynthesis , Receptor, ErbB-2*/genetics, Aged ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Survival Rate

المؤلفون: Głodzik D; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Wellcome Trust Sanger Institute, Hinxton, Cambridge., Purdie C; Department of Pathology, Ninewells Hospital & Medical School, Dundee, UK., Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Simpson PT; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Span PN; Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway., Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, Cambridge; Academic Department of Medical Genetics, The Clinical School University of Cambridge, Cambridge, UK. Electronic address: sn206@cam.ac.uk.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Nov 01; Vol. 29 (11), pp. 2223-2231.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Gene Amplification* , Translocation, Genetic*, Breast Neoplasms/*genetics , Genetic Loci/*genetics, Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Algorithms ; Breast/pathology ; Breast Neoplasms/pathology ; Carrier Proteins/genetics ; Chromosomes, Human, Pair 11/genetics ; Chromosomes, Human, Pair 8/genetics ; Cyclin D1/genetics ; Datasets as Topic ; Female ; Genomics/methods ; Humans ; Middle Aged ; Oncogenes/genetics ; Receptor, Fibroblast Growth Factor, Type 1/genetics ; Whole Genome Sequencing